In patients with pulmonary arterial hypertension, Neb but not Met decreased the expression of pro-inflammatory cytokines, such as IL-6 and MCP-1, in pulmonary endothelial cells in a dose-dependent manner. This evidence concerns the gene CCL2 and pulmonary arterial hypertension.